^
TNFRSF8 positive
Cutaneous T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
No biomarker
Cutaneous T-cell Lymphoma
bexarotene oral
Sensitive
:
A1
No biomarker
Cutaneous T-cell Lymphoma
vorinostat
Sensitive
:
A1
IL2RA expression
Cutaneous T-cell Lymphoma
denileukin diftitox
Sensitive
:
A1
No biomarker
Cutaneous T-cell Lymphoma
denileukin diftitox
Sensitive
:
A1
No biomarker
Cutaneous T-cell Lymphoma
RP6530
Sensitive
:
B
TNFRSF8 expression
Cutaneous T-cell Lymphoma
brentuximab vedotin
Sensitive
:
C1
PD-L1 underexpression
Cutaneous T-cell Lymphoma
durvalumab + lenalidomide
Sensitive
:
C3
RPS6 underexpression
Cutaneous T-cell Lymphoma
ruxolitinib
Sensitive
:
C3
ICOS underexpression
Cutaneous T-cell Lymphoma
durvalumab
Sensitive
:
C3
PD-1 overexpression
Cutaneous T-cell Lymphoma
pembrolizumab
Sensitive
:
C3
CD70 expression
Cutaneous T-cell Lymphoma
ARGX-110
Sensitive
:
C3